If you or someone you love has sickle cell anemia and has noticed yellowing of the eyes, here’s what’s happening: sickle-shaped red blood cells are fragile and break apart much faster than normal cells. A healthy red blood cell lives about 120 days. In sickle cell disease, that lifespan drops to roughly 10–20 days. When red blood cells break down (a process called hemolysis), they release a yellow pigment called bilirubin. Your liver can’t clear it fast enough, so bilirubin accumulates — and the whites of your eyes turn yellow.
This yellowing is called scleral icterus (when it’s in the eyes) or jaundice (when it affects the skin too). In sickle cell patients, some degree of yellow eyes is almost always present and is often the most visible day-to-day sign of the disease. But the intensity can fluctuate — and a sudden deepening of that yellow color can signal a serious complication that needs immediate medical attention.
Why Do Sickle Cell Patients Get Yellow Eyes?
Normal hemoglobin (HbA) keeps red blood cells smooth, round, and flexible. In sickle cell anemia, a single amino acid substitution (valine replacing glutamic acid at position 6 of the beta-globin chain) produces hemoglobin S (HbS). Under low-oxygen conditions, HbS polymerizes and forces the cell into a rigid crescent or sickle shape.
These misshapen cells get trapped in small blood vessels and are destroyed by the spleen and liver at an accelerated rate. The constant destruction generates a chronic surplus of unconjugated (indirect) bilirubin, which the liver converts to conjugated bilirubin for excretion. But the sheer volume of hemolysis overwhelms the system.
The result: baseline bilirubin levels in sickle cell patients typically run 2–4 mg/dL, compared to the normal range of 0.1–1.2 mg/dL. Scleral icterus becomes clinically visible once total bilirubin exceeds about 2.5–3.0 mg/dL — a threshold most sickle cell patients sit at or above chronically.
Bilirubin Levels in Sickle Cell Disease vs. Normal
| Parameter | Normal Range | Typical in Sickle Cell Anemia | During Crisis or Complication |
|---|---|---|---|
| Total bilirubin | 0.1–1.2 mg/dL | 2–4 mg/dL | Can exceed 10–15 mg/dL |
| Indirect (unconjugated) bilirubin | 0.1–0.8 mg/dL | 1.5–3.5 mg/dL | Rises sharply |
| Reticulocyte count | 0.5–1.5% | 5–15% | May drop (aplastic crisis) or surge |
| LDH | 140–280 U/L | Often 300–800 U/L | Can exceed 1,000 U/L |
| Hemoglobin | 12–16 g/dL | 6–9 g/dL | May fall below 5 g/dL |
When Yellow Eyes Get Worse: Red Flags to Watch For
Chronic mild jaundice is the baseline for most sickle cell patients. But a noticeable worsening of yellow eyes — especially when paired with other symptoms — can indicate a dangerous complication:
- Aplastic crisis: Parvovirus B19 infection temporarily shuts down red blood cell production. Bilirubin may paradoxically stabilize, but hemoglobin plummets. The reticulocyte count drops to near zero.
- Hepatic sequestration: Sickled cells clog liver sinusoids, causing a rapid rise in direct and indirect bilirubin, liver enlargement, and right upper quadrant pain.
- Splenic sequestration: More common in children under 5. The spleen traps large volumes of blood, causing sudden severe anemia and deepening jaundice.
- Gallstones (pigmented cholelithiasis): Years of excess bilirubin lead to calcium bilirubinate gallstones in up to 50–70% of sickle cell patients by adulthood. A blocked bile duct causes dark urine, clay-colored stools, and sharply elevated conjugated bilirubin.
- Acute hemolytic crisis: Infections, dehydration, or exposure to extreme temperatures can trigger a wave of accelerated hemolysis.
Diagnosis: How Sickle Cell Anemia Is Confirmed
Hemoglobin electrophoresis is the gold-standard test. It separates hemoglobin types and identifies HbS. In sickle cell anemia (HbSS), hemoglobin electrophoresis typically shows 80–95% HbS, with the remainder being HbF (fetal hemoglobin) and small amounts of HbA2. HbA is absent.
In the United States and many other countries, newborn screening programs catch sickle cell disease within the first days of life. For adults who weren’t screened, a sickle solubility test (Sickledex) provides a rapid screen, but electrophoresis or HPLC is needed for confirmation.
When evaluating worsening jaundice in a known sickle cell patient, doctors will typically order a complete blood count, reticulocyte count, total and fractionated bilirubin, LDH, haptoglobin, liver function tests, and a right upper quadrant ultrasound to look for gallstones or hepatic complications.
Treatment: Managing Jaundice in Sickle Cell Disease
You can’t fully eliminate jaundice in sickle cell anemia without addressing the underlying hemolysis. Current treatments aim to reduce sickling and slow red blood cell destruction:
- Hydroxyurea: The most established disease-modifying therapy. It increases fetal hemoglobin (HbF) production, which inhibits HbS polymerization. Studies show it reduces pain crises by ~44% and can modestly improve hemoglobin levels. Many patients notice their jaundice lightens after several months on hydroxyurea.
- L-glutamine (Endari): FDA-approved in 2017, it reduces oxidative stress in sickle cells and decreases hospital visits.
- Voxelotor (Oxbryta): Directly inhibits HbS polymerization by increasing hemoglobin’s oxygen affinity. In clinical trials, 51% of patients achieved a hemoglobin increase of more than 1 g/dL, and bilirubin levels decreased significantly.
- Crizanlizumab (Adakveo): A monoclonal antibody targeting P-selectin that reduces vaso-occlusive crises.
- Blood transfusions: Regular transfusion programs dilute HbS with normal HbA, reducing sickling and hemolysis. Used for severe complications or when hemoglobin drops dangerously low.
- Cholecystectomy: When pigmented gallstones cause recurrent biliary symptoms or obstruction, surgical removal of the gallbladder is often recommended — sometimes electively.
- Gene therapy: Casgevy (exagamglogene autotemcel), approved by the FDA in December 2023, offers a potential cure by editing the patient’s own stem cells to produce high levels of fetal hemoglobin.
When to See a Doctor
Mild, stable jaundice in a known sickle cell patient is expected. But seek urgent medical evaluation if you notice:
- A sudden, noticeable increase in yellow discoloration of the eyes or skin
- Dark tea- or cola-colored urine
- Severe fatigue, dizziness, or shortness of breath (signs of worsening anemia)
- Right upper abdominal pain (possible gallstone complications or hepatic sequestration)
- Fever above 101.3°F (38.5°C) — sickle cell patients are functionally asplenic and at high risk for overwhelming infection
- A child’s abdomen suddenly becoming distended (possible splenic sequestration — this is a medical emergency)
Frequently Asked Questions
Is it normal for someone with sickle cell anemia to always have yellow eyes?
Yes. Because sickle-shaped red blood cells are constantly being destroyed, most patients with HbSS disease have chronically elevated bilirubin and some degree of scleral icterus. The intensity varies from person to person and can fluctuate with hydration, illness, or medication changes. A stable, mild yellow tint is generally not cause for alarm on its own.
Can sickle cell trait (carrier status) cause yellow eyes?
Sickle cell trait (HbAS) causes minimal to no hemolysis under normal conditions, and carriers typically don’t develop jaundice. However, under extreme physiological stress — severe dehydration, very high altitude, or intense exertion — some sickling and mild hemolysis can occur. Persistent yellow eyes in someone with sickle cell trait warrants investigation for other causes, such as Gilbert syndrome or liver disease.
Will hydroxyurea make the yellow eyes go away?
It can reduce them. By boosting fetal hemoglobin production, hydroxyurea makes red blood cells less likely to sickle and extends their lifespan. This reduces the rate of hemolysis and lowers bilirubin. Many patients on hydroxyurea notice their jaundice becoming less pronounced over weeks to months, though it may not disappear entirely.
How can I tell if yellow eyes are from sickle cell or a liver problem?
In sickle cell hemolysis, the indirect (unconjugated) bilirubin is elevated, and direct bilirubin stays relatively normal. Liver disease or bile duct obstruction causes the direct (conjugated) bilirubin to rise, often with elevated liver enzymes (ALT, AST, ALP), dark urine, and pale stools. A simple fractionated bilirubin blood test can distinguish the two. If both are elevated in a sickle cell patient, it may suggest gallstone disease or sickle cell hepatopathy — both of which need prompt workup.
Do sickle cell patients need their gallbladder removed?
Not all of them, but many do. Chronic excess bilirubin leads to pigmented gallstones in a large percentage of patients, sometimes starting in childhood. If gallstones cause symptoms — episodes of right upper abdominal pain after eating, nausea, or complications like cholecystitis or bile duct obstruction — cholecystectomy is typically recommended. Some hematologists advocate for elective removal when stones are found, even before symptoms develop, to avoid emergency surgery during a crisis.
